C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact.Continue reading
Category Archives: AZBio News
C-Path Announces Key Leadership Appointments in Neurodegenerative Disease Research
Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPADContinue reading
Applications for the Flinn Foundation Bioscience Entrepreneurship Program Open
The Flinn Foundation Bioscience Entrepreneurship Program application is open November 4, 2024 to December 16, 2024. This year, the program is piloting a new format as we await an update of Arizona’s Bioscience Roadmap that will extend beyond 2025. Continue reading
BioLab Holdings, Inc. Launches Charity Care Program to Serve Uninsured
Wound Care Manufacturer to Donate Advanced Skin Substitutes to Qualifying Patients in NeedContinue reading
U of A Health Sciences breaks ground on the Center for Advanced Molecular and Immunological Therapies
Construction is underway on the new building that will house the University of Arizona Health Sciences Center for Advanced Molecular and Immunological Therapies, or CAMI, on the Phoenix Bioscience Core in downtown Phoenix.Continue reading
2025 KEYS Internship Applications Open
Applications for KEYS 2025 are open from Friday November 1st to December 13, 2024. This is an incredible opportunity for high school students to gain real-world scientific experience at the University of Arizona. The program will run from from June 2 – July 18, 2025. Continue reading
TGen’s Nicholas Banovich, Ph.D., Secures Over $8.2 Million in NIH Grants for Pulmonary Disease Research
PHOENIX, AZ (October 30, 2024) – Nicholas Banovich, Ph.D., associate professor and division director of Bioinnovation and Genome Sciences at TGen, part of City of Hope, will lead or co-lead three collaborative grants totaling over $22 million, with $8.2 million supporting research at TGen. These grants, awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI), will support innovative research to uncover the molecular drivers of pulmonary diseases, with the goal of improving prevention, diagnosis, and treatment.Continue reading
Accomplished scientist and executive Díaz de la Rubia selected to lead U of A research enterprise
Accomplished scientist and executive Díaz de la Rubia selected to lead U of A research enterpriseContinue reading
TGen and partners in Longevity Consortium receive $45 million grant
The five-year grant will integrate studies of factors contributing to longer and healthier livesContinue reading